Phase II trial of neoadjuvant combination chemotherapy with gemcitabine and S-1 for locally advanced pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 18 May 2016
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 13 May 2016 Status changed from recruiting to completed.
- 17 Dec 2009 Planned end date (Sep 2011) added as reported by University Hospital Medical Information Network - Japan.
- 22 Oct 2008 New trial record.